Exercise is important for body composition promotion. Although many studies have indicated that physical competence promotes exercise participation, there are relatively few studies examining the relationships among these factors. The purpose of the present study was to model the relationships among body composition, exercise habits and physical competence by using structural equation modeling. The subjects were 223 Japanese male and female high school students. Height, lean bone mass and bone area ratio were measured. Exercise habits and physical competence scale including three subscales (perceived physical competence, feeling of control and peer and teacher acceptance) were assessed by self-administered questionnaires. Data were analyzed using structural equation modeling. The model showed acceptable fit indices (GFI = .905, AGFI = .863 CFI = .954, RMSEA = .069). The path from peer and teacher acceptance to exercise habit was significant (β = 0.51, p < .001). Moreover, the path from exercise habits and from perceived physical competence to body composition was significant (respectively β = 0.53; p < .001, β = 0.47, p < .001). We could model the relationships among body composition, exercise habits and physical competence. These results indicate that not only exercise habits but also physical competence promoting exercise participation influence on body composition promotion.

OBJECTIVE: To test the concept of taxane sequencing, this feasibility trial evaluated maintenance of docetaxel after paclitaxel and carboplatin combination chemotherapy in patients with stage IC-IV ovarian cancer. METHODS: All patients received debulking surgery followed by paclitaxel and carboplatin chemotherapy. Attainment of clinically defined complete or partial response was confirmed by image scanning. Maintenance of docetaxel started at an initial dose of 70 mg/m2 every 4 weeks for 6 cycles and was extended to 10 cycles unless disease progression and/or recurrence during the protocol therapy or unacceptable toxicities were seen. RESULTS: Stage subsets in 20 eligible patients were as follows: IIIB, 2 patients (10%); IIIC, 13 patients (65%); IV, 5 patients (25%). Neutropenia was common (40% with grade 3 or 4) and was most frequent during first or second cycle although the disabling peripheral neuropathy was not observed. Twelve patients completed protocol therapy (6< or =cycles), while 8 patients failed to complete 6-cycle chemotherapy, because of progressive disease (5 patients) or grade 4 toxicities (3 patients). Median PFS was 20 months and 3-year PFS rate was 12%. Median overall survival was 39 months and 3-year OS rate was 69%. CONCLUSION: Six cycles of single-agent docetaxel maintenance chemotherapy is feasible and generally tolerable to women with advanced ovarian cancer who attained a clinically defined response to initial paclitaxel and carboplatin based chemotherapy.
Bridged Compounds ; Carboplatin ; Disease Progression ; Drug Therapy, Combination ; Feasibility Studies ; Female ; Humans ; Maintenance Chemotherapy ; Neutropenia ; Ovarian Neoplasms ; Paclitaxel ; Peripheral Nervous System Diseases ; Recurrence ; Taxoids